Dr. Nima Sharifi, MD of Cleveland Clinic discusses the potential role for combinations of CYP17 inhibitors and AR inhibitors in Castration Resistant Prostate Cancer at ASCO GU 2016 in San Francisco.
Advertisement
[the_ad id="32629"]
Potential role for combinations of CYP17 inhibitors and AR inhibitors in Castration Resistant Prostate Cancer
By Editor